IGHG3 and esophageal cancer: Based on our previously published research (36–38), IgG4 is significantly elevated in esophageal cancer patients and closely related to immune suppression, which is the primary focus of this study, and the levels of IgG2 and IgG3 are comparatively low, and their antitumor roles are relatively minor or unknown (39).